Is Taurine Sleep Latency Randomized Trial safe?

The current Migaku evidence database contains 1 reusable source document for Taurine Sleep Latency Randomized Trial. This answer focuses on safety, limits, and clinician-discussion contexts. - Risk of bias was assessed using RoB-2 (Risk of Bias 2, including crossover extension) and ROBINS-I (Risk Of Bias In Nonrandomized Studies of Interventions). [Chmiel J (2026); evidence level 3] - The evidence most consistently supported stage- and context-dependent modulation. [Chmiel J (2026); evidence level 3] - P300 amplitude findings were mixed and context-dependent: amplitude was often unchanged in rested or low-demand paradigms, but increased or was restored when caffeine counteracted fatigue, sleep loss, sustained attention demands, or high workload. [Chmiel J (2026); evidence level 3] - Introduction Caffeine is a widely consumed adenosine receptor antagonist with well-documented effects on arousal and performance, but its time-resolved neurophysiological signature across stages of information processing remains fragmented across event-related potential (ERP) paradigms. [Chmiel J (2026); evidence level 3] Evidence levels are sorting aids, not final clinical grades. Level 1 usually indicates systematic-review style evidence, level 2 indicates randomized trials or public-health guidance, and lower levels need more cautious wording. This page is educational. People with medical conditions, pregnancy, medication use, or unusual symptoms should ask a qualified clinician before changing supplements, medication, or treatment routines.